Inspire Medical Systems, Inc. INSP 深 滬
等待開盤 11-26 09:30:00 美东时间
130.39
+13.100
+11.17%
華盛通- 最 高138.80
- 今 開120.48
- 成交量 560.56万股
- 最 低 120.22
- 昨 收 117.29
- 總市值 38.56亿
- 52周最高 216.01
- 市盈率 靜 74.43
- 換手率 0.02%
- 52周最低 70.77
- 委 比 -81.82%
- 總股本 2957.43万
- 歷史最高 330.00
- 量 比 3.10
- 振 幅 15.84%
- 歷史最低 22.50
- 每 手 1
- 風險率 42.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
12分钟前
Wolfe Research Upgrades Inspire Medical Systems to Outperform, Announces $180 Price Target
Wolfe Research analyst Mike Polark upgrades Inspire Medical Systems (NYSE:INSP) from Peer Perform to Outperform and announces $180 price target.
11-25 23:58
美股牛股 | OSCR大涨超22%，白宫计划延长奥巴马医改补贴；加密财库公司BitMine大涨19.6%
OSCR大涨超22%，白宫计划延长奥巴马医改补贴；加密财库公司BitMine大涨19.6%，持有3%的ETH代币供应量>>
11-25 15:10
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
11-25 10:27
Alibaba, Oscar Health, Ondas Holdings, Lumentum, Tesla And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones gaining around 250 points on Monday...
11-25 00:06
Inspire jumps on major change to Medicare reimbursement
Shares of Inspire Medical Systems (INSP) are up ~28% in Monday trading after CMS dramatically boosted 2026 reimbursement rates for codes the company uses as part of the procedure for implanting its sl...
11-24 23:45
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Inspire Veterinary (NASDAQ:IVP) stock increased by 77.5% to $0.22 duri...
11-24 20:05
Inspire Medical Systems to Release Tax Valuation Allowance
Inspire Medical Systems ( ($INSP) ) has shared an update. On November 6, 2025, ...
11-18 05:56
Inspire Medical Faces Legal Heat Over Product Launch
In a dramatic turn of events, Inspire Medical Systems, Inc. finds itself at the...
11-12 00:15
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
